Table 7.

Univariate models of cost and medical personnel utilization per patient that remained in care for one full year (n = 169)

Treatment cost	Relative difference	95% CI	p-value
Hospitalized during ART (n = 8)	1.79	(1.40, 2.28)	<0.0001
ART changed due to side effects (n = 21)	1.35	(1.15, 1.59)	0.0002
Treated for TB (n = 20)	1.2	(1.02, 1.43)	0.0276
CDC Stage C (n = 98)	1.14	(1.02, 1.27)	0.0199
Physician time	Relative difference	95% CI	p-value
Treated for TB (n = 20)	1.83	(1.52, 2.21)	<0.0001
ART changed due to side effects (n = 21)	1.36	(1.01, 1.87)	<0.0001
CDC Stage C (n = 98)	1.35	(1.18, 1.54)	<0.0001
No income (n = 94)	1.21	(1.06, 1.39)	0.0046
Hemoglobin <10 mg/dl at baseline (n = 44)	1.18	(1.01, 1.38)	0.0321
Body weight in the bottom quartile at baseline (n = 33)	1.19	(1.01, 1.41)	0.0479
Female gender (n = 94)	1.16	(1.01, 1.33)	0.0301
Nurse time	Relative difference	95% CI	p-value
Treated for TB (n = 20)	2.00	(1.70, 2.33)	<0.0001
ART changed due to side effects (n = 21)	1.21	(1.01, 1.46)	0.0437
CDC Stage C (n = 98)	1.18	(1.04, 1.33)	0.0309